Comparative effectiveness of therapies for C. difficile infection
FMT for type 1 diabetes plus severe GI neuropathy
Physicians’ adenoma detection rates and subsequent CRC risk
Audit of functional GI disorders care in South Australia
Audit of eosinophilic oesophagitis in paediatric Australasians
Cost effectiveness of vibrating capsules for chronic idiopathic constipation
Management of refractory reflux-like symptoms despite PPIs
Novel oesophageal corticosteroid delivery system for eosinophilic oesophagitis
C. difficile colonisation/infection in vedolizumab recipients with IBD
IBD increases herpes zoster complications risk
Please login below to download this issue (PDF)